The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
JTO Clinical and Research Reports
(Nov 2020)
Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
Catherine Daniel, MD, PhD,
Celine Callens, PharmD, PhD,
Samia Melaabi, MD,
Ivan Bieche, PharmD, PhD,
Nicolas Girard, MD, PhD
Affiliations
Catherine Daniel, MD, PhD
Oncology Department, Institut Curie, Paris, France; Corresponding author. Address for correspondence: Catherine Daniel, MD, PhD, Oncology Department, Institut Curie, 26 rue d’Ulm, 75005 Paris, France.
Celine Callens, PharmD, PhD
Genetics Department Institut Curie, Paris, France
Samia Melaabi, MD
Genetics Department Institut Curie, Paris, France
Ivan Bieche, PharmD, PhD
Genetics Department Institut Curie, Paris, France
Nicolas Girard, MD, PhD
Oncology Department, Institut Curie, Paris, France
Journal volume & issue
Vol. 1, no. 4
p. 100082
Abstract
Read online
No abstracts available.
WeChat QR code
Close